Summit Therapeutics (SMMT)'s 30-day implied volatility (IV30) was 119.1% at the close on October 23, 2026, up from 62.5% the day before, against a 52-week range of 43.5% to 164.0%. Its 20-day historical volatility was 69.1%.
Data as of October 23, 2026.